As more states move to decriminalize cannabis, the regulatory framework becomes more complicated. How can companies successfully navigate...
The FDA issued warning letters to several CBD companies for selling unapproved products with unsubstantiated medical claims.
Not all products have to meet the U.S. Federal Drug Administration’s (FDA) approval: certain biologics and dietary supplements do not...
The US Food and Drug Administration (FDA) has announced new restrictions concerning the marketing of tobacco products such as e-cigarettes...
Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly...
Colorado passed a law requiring drug manufacturers to disclose the wholesale acquisition cost to prescribers in its effort to address the...
